—
C+
C+ The full Closelook — membership. Open the C+ overview

Sanofi ADR (SNY) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Sanofi ADR

SNY in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sanofi researches, manufactures and sells medicines and vaccines across immunology, rare neurological disease, oncology and childhood immunisation, including combination vaccines for several infections at once. It also runs a wide set of collaborations with smaller biotech and computational firms, several of them using machine-learning platforms to search for new drug candidates. The company is based in Paris and was known as Sanofi-Aventis before it took its current name.
Where it sits in the stack
Sanofi carries no seat in our index and sits outside the layered AI build-out that our index tracks; it belongs to the pharmaceuticals sleeve of the wider universe the diary follows for its own sake, not as an input to chips, data centres or models.
Who it is priced against
Closelook has not assigned it a peer group; the comparison the market usually draws is with other large diversified drugmakers such as Pfizer.
Why Closelook tracks it
It holds no seat in our index and no Closelook score module has been built for it. It has appeared once in the diary, in a Daily Pulse edition that named it among defensives alongside McDonald's, ExxonMobil and Unilever, with Palantir as the single high-beta name in that session.
What the diary watches
Whether any of its AI-assisted drug-discovery collaborations move from early research into named clinical candidates, which would give the diary a genuine AI angle on the stock rather than a defensive one.

Sanofi ADR (SNY) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for SNY, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: initiation by RBC Capital, 2026-09-08

The Street on this name

Analyst actions and the latest print for SNY from the Closelook wires — third-party opinions on the record, not our readings.

  • Initiation RBC Capital — at Sector Perform Initiated to Sector Perform 2026-09-08

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Sanofi ADR (SNY)?

Sanofi ADR trades as SNY on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-18.

Is SNY in a Closelook index?

Not currently — Sanofi ADR is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does SNY trade against its moving averages?

Downtrend stack: Trades -1.8% vs the 50-day and -2.3% vs the 200-day average, 13.6% below the 52-week high and +5.5% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Sanofi ADR do?

Sanofi researches, manufactures and sells medicines and vaccines across immunology, rare neurological disease, oncology and childhood immunisation, including combination vaccines for several infections at once. It also runs a wide set of collaborations with smaller biotech and computational firms, several of them using machine-learning platforms to search for new drug candidates. The company is based in Paris and was known as Sanofi-Aventis before it took its current name. Closelook has not assigned it a peer group; the comparison the market usually draws is with other large diversified drugmakers such as Pfizer.

Where does Sanofi ADR sit in the AI build-out?

Sanofi carries no seat in our index and sits outside the layered AI build-out that our index tracks; it belongs to the pharmaceuticals sleeve of the wider universe the diary follows for its own sake, not as an input to chips, data centres or models. It holds no seat in our index and no Closelook score module has been built for it. It has appeared once in the diary, in a Daily Pulse edition that named it among defensives alongside McDonald's, ExxonMobil and Unilever, with Palantir as the single high-beta name in that session.

What has Wall Street done on Sanofi ADR recently?

The most recent analyst action on Sanofi ADR on the Closelook wire is a initiation by RBC Capital on 2026-09-08 (at Sector Perform). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelook written about Sanofi ADR?

Sanofi ADR appears in 1 Closelook piece, most recently Daily Pulse: Temperature 59 Risk-On as AW25 Surges 5.3% in Single Session (2026-04-16). What Closelook said most recently: The top names — MCD, XOM, UL, PLTR, SNY — span defensives, energy, and a single high-beta name in Palantir. (Daily Pulse, 2026-04-16). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for SNY, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 1 piece · newest: Daily Pulse, “Temperature 59 Risk-On as AW25 Surges 5.3% in Single Session” (2026-04-16)

Mentioned on Closelook

Where SNY appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies